The Secretariat is happy to consider articles for publication on this website about anti-leprosy activities, including disability and development-related issues.
If you have some news, a story to share or an idea for an article, please contact ILEP by writing to: ilep@ilep.org.uk
Discover the real stories...
Chemoprophylaxsis in the prevention of leprosy/COLEP study
Posted on 26 April 2008 by
In an editorial published in the British Medical Journal (BMJ) April 2008, entitled Chemoprophylaxsis in the treatment of leprosy, ITC Chair, Professor W. Cairns S Smith asserts that 'national policies need to be reviewed in the light of new evidence supporting a single dose of rifampicin.'
The associated article discusses the results of the COLEP study in Bangladesh:
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
By F Johannes Moet, David Pahan, Linda Oskam and Jan H Richardus for the COLEP study group.
Categories
Archive
- June 2008 (6)
- May 2008 (9)
- April 2008 (8)
- March 2008 (2)
- February 2008 (5)
- January 2008 (4)
- December 2007 (5)
- November 2007 (7)
- October 2007 (2)
- September 2007 (3)
- August 2007 (3)
- July 2007 (3)
- May 2007 (2)
- April 2007 (2)
- March 2007 (1)
- February 2007 (3)
- January 2007 (4)
- December 2006 (2)
- November 2006 (1)
- October 2006 (1)
- September 2006 (1)
- June 2006 (1)